Is a stromal tumor in the stomach and duodenum a malignant tumor?

Gastroduodenal stromal tumors are not necessarily malignant tumors. Gastrointestinal stromal tumors (GISTs) are tumors that occur in the stomach or intestines and can be benign or malignant. Their nature depends on the size, location, cell division rate, and genetic mutation characteristics of the tumor. Usually, doctors will perform a more in-depth evaluation through imaging tests such as CT or MRI and tissue biopsy to determine the nature of the tumor.

Gastrointestinal stromal tumor is a tumor that originates from the interstitial cells between the walls of the digestive tract. Its exact cause is still unclear, but it is related to mutations in the KIT or PDGFRA genes. Genetic factors account for a small proportion of the incidence of stromal tumors, and it is difficult to determine the direct impact of environmental factors, such as eating habits and lifestyle. Stromal tumors generally have no obvious history of previous trauma and are discovered accidentally during physical examinations in most cases. Common symptoms include abdominal pain, indigestion, gastrointestinal bleeding, or abdominal masses caused by tumors.

Gastrointestinal stromal tumor is a tumor that originates from the interstitial cells between the walls of the digestive tract. Its exact cause is still unclear, but it is related to mutations in the KIT or PDGFRA genes. Genetic factors account for a small proportion of the incidence of stromal tumors, and it is difficult to determine the direct impact of environmental factors, such as eating habits and lifestyle. Stromal tumors generally have no obvious history of previous trauma and are discovered accidentally during physical examinations in most cases. Common symptoms include abdominal pain, indigestion, gastrointestinal bleeding, or abdominal masses caused by tumors.

In general, common methods for treating gastroduodenal stromal tumors include surgical resection, targeted drug therapy, and radiotherapy. Surgical resection is the main method for treating stromal tumors, especially when the tumor is small and confined to a certain location. Targeted drugs such as imatinib, sunitinib, and regorafenib play an important role in inoperable or metastatic stromal tumors. Patients should have regular checkups during treatment to monitor the treatment effect and tumor changes. They should pay attention to a light diet, avoid irritating foods, and maintain a healthy weight. Pay attention to regular physical examinations, especially for patients with a family history or digestive tract diseases. If you experience any discomfort, you should seek medical attention as soon as possible to obtain a timely and accurate diagnosis and treatment plan.